(Q35194758)

7 August 2017

1 reference

title

Mild cognitive impairment clinical trials (English)

1 reference

mild cognitive impairment

7 August 2017

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

1

Ronald C Petersen

1 reference

7 August 2017

1 August 2003

1 reference

Nature Reviews Drug Discovery

7 August 2017

1 reference

7 August 2017

2

1 reference

7 August 2017

646-653

1 reference

7 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd1155

7 August 2017

0 references

cites work

Neuropathological stageing of Alzheimer-related changes

1 reference

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

31 March 2020

1 reference

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

31 March 2020

1 reference

Aging, mild cognitive impairment, and Alzheimer's disease

31 March 2020

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

31 March 2020

1 reference

Aging-Associated Cognitive Decline

31 March 2020

1 reference

Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

31 March 2020

1 reference

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.

31 March 2020

1 reference

Natural history of mild cognitive impairment in older persons

31 March 2020

1 reference

Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging

31 March 2020

1 reference

Classification criteria for mild cognitive impairment: a population-based validation study

31 March 2020

1 reference

Mild cognitive impairment in the elderly: predictors of dementia

31 March 2020

1 reference

Predicting conversion to Alzheimer disease using standardized clinical information.

31 March 2020

1 reference

Progression to dementia in patients with isolated memory loss.

31 March 2020

1 reference

Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.

31 March 2020

1 reference

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

31 March 2020

1 reference

A new clinical scale for the staging of dementia.

31 March 2020

1 reference

The Clinical Dementia Rating (CDR): current version and scoring rules

31 March 2020

1 reference

The Global Deterioration Scale for assessment of primary degenerative dementia

31 March 2020

1 reference

Mild cognitive impairment or questionable dementia?

31 March 2020

1 reference

Mild cognitive impairment: clinical characterization and outcome

31 March 2020

1 reference

Current concepts in mild cognitive impairment

31 March 2020

1 reference

Cholinergic markers in elderly patients with early signs of Alzheimer disease.

31 March 2020

1 reference

Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease

31 March 2020

1 reference

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

31 March 2020

1 reference

Memantine in moderate-to-severe Alzheimer's disease

31 March 2020

1 reference

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

31 March 2020

1 reference

Amyloid, the presenilins and Alzheimer's disease

31 March 2020

1 reference

Processing of the Alzheimer's Disease ΒZA4 Amyloid Protein Precursor (APP)

31 March 2020

1 reference

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

31 March 2020

1 reference

Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase

31 March 2020

1 reference

Purification and cloning of amyloid precursor protein beta-secretase from human brain

31 March 2020

1 reference

Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity

31 March 2020

1 reference

Alzheimer's disease. A partner for presenilin.

31 March 2020

1 reference

Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease.

31 March 2020

1 reference

Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis.

31 March 2020

1 reference

Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.

31 March 2020

1 reference

Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal

31 March 2020

1 reference

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain.

31 March 2020

1 reference

Inflammatory mechanisms in Alzheimer's disease: implications for therapy

31 March 2020

1 reference

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

31 March 2020

1 reference

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

31 March 2020

1 reference

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

31 March 2020

1 reference

Telephone screening for amnestic mild cognitive impairment

31 March 2020

1 reference

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

31 March 2020

1 reference

Postmenopausal estrogen replacement therapy and risk of AD: a population-based study.

31 March 2020

1 reference

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

31 March 2020

1 reference

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

31 March 2020

1 reference

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

31 March 2020

1 reference

Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans.

31 March 2020

1 reference

Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report

31 March 2020

1 reference

Clinical efficacy of piracetam in cognitive impairment: a meta-analysis

31 March 2020

1 reference

Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which?

31 March 2020

1 reference

Sex differences in neurochemical markers that correlate with behavior in aging mice.

31 March 2020

1 reference

31 March 2020

1 reference

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

31 March 2020

1 reference

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

31 March 2020

1 reference

Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study.

31 March 2020

1 reference

A new rating scale for Alzheimer's disease.

31 March 2020

1 reference

The short test of mental status. Correlations with standardized psychometric testing.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD1155

1 reference

7 August 2017

1 reference

PubMed ID

12904814